LifeVantage (NASDAQ:LFVN) Releases FY 2025 Earnings Guidance

LifeVantage (NASDAQ:LFVN) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.700-0.800 for the period, compared to the consensus estimate of 0.700. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $205.8 million.

LifeVantage Price Performance

NASDAQ LFVN opened at $7.96 on Friday. LifeVantage has a 1 year low of $4.20 and a 1 year high of $9.14. The firm has a market cap of $101.10 million, a price-to-earnings ratio of 28.43 and a beta of 0.81. The company has a fifty day moving average price of $7.26 and a 200-day moving average price of $6.95.

LifeVantage (NASDAQ:LFVN) last posted its earnings results on Wednesday, August 28th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.07). LifeVantage had a return on equity of 27.02% and a net margin of 1.75%. The firm had revenue of $48.93 million during the quarter.

LifeVantage Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 17th. Investors of record on Monday, September 9th will be given a dividend of $0.04 per share. The ex-dividend date is Monday, September 9th. This represents a $0.16 annualized dividend and a yield of 2.01%. LifeVantage’s payout ratio is currently 57.14%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.